Form 8-K - Current report:
SEC Accession No. 0001559053-24-000005
Filing Date
2024-02-21
Accepted
2024-02-21 16:06:56
Documents
14
Period of Report
2024-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K prta-20240221.htm   iXBRL 8-K 31807
  Complete submission text file 0001559053-24-000005.txt   165252

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20240221.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20240221_lab.xml EX-101.LAB 25652
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20240221_pre.xml EX-101.PRE 13538
15 EXTRACTED XBRL INSTANCE DOCUMENT prta-20240221_htm.xml XML 2933
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 24659415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)